Edwards Lifesciences Corp...

NYSE: EW · Real-Time Price · USD
78.18
0.50 (0.64%)
At close: Aug 14, 2025, 3:59 PM
78.99
1.04%
Pre-market: Aug 15, 2025, 07:01 AM EDT

Edwards Lifesciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.44B 5.01B 5.38B 5.23B
Cost of Revenue
1.15B 1.04B 1.17B 1.23B
Gross Profit
4.29B 3.97B 4.22B 4.01B
Operating Income
1.44B 1.43B 1.7B 1.61B
Interest Income
120.3M 67.2M 35.5M 17.4M
Pretax Income
1.55B 1.37B 1.77B 1.7B
Net Income
4.17B 1.4B 1.52B 1.5B
Selling & General & Admin
1.79B 1.58B 1.57B 1.49B
Research & Development
1.05B 962.9M 945.2M 903.1M
Other Expenses
-300K n/a n/a n/a
Operating Expenses
2.84B 2.55B 2.51B 2.4B
Interest Expense
19.8M 17.6M 26.2M 24.8M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4B 3.58B 3.68B 3.62B
Income Tax Expense
152.1M 152.4M 245.5M 198.9M
Shares Outstanding (Basic)
597.7M 606.7M 619M 623.3M
Shares Outstanding (Diluted)
599.3M 609.4M 624.2M 631.2M
EPS (Basic)
6.98 2.31 2.46 2.41
EPS (Diluted)
6.97 2.30 2.44 2.38
EBITDA
1.72B 1.53B 1.96B 1.89B
EBIT
1.57B 1.39B 1.79B 1.73B
Depreciation & Amortization
155.2M 144.9M 166.8M 163.3M